文献速递肝病消化道肿瘤与早癌

PNPLA3与TM6SF2基因变异增加酒精性肝硬化患者肝细胞癌发生风险

Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2018-03-13

在751例酒精性肝硬化合并肝细胞癌患者与1165例酒精性肝硬化无肝细胞癌对照中,采用多因素logistic回归分析基因变异与肝细胞癌风险的关联;PNPLA3 rs738409与TM6SF2 rs58542926为独立风险因素,MBOAT7 rs641738无显著关联;两变异同时携带的人群归因分数为49.9%。

要点

  • PNPLA3 rs738409与TM6SF2 rs58542926均为酒精性肝硬化患者发生肝细胞癌的独立风险因素。
  • MBOAT7 rs641738与肝细胞癌风险无显著关联(ORadjusted 1.04,95%CI 0.88-1.24,p=0.61)。
  • 同时携带PNPLA3与TM6SF2两变异的人群归因分数为49.9%。

核心结论

  • 携带TM6SF2 rs58542926是酒精性肝硬化患者发生肝细胞癌的另一风险因素。
  • 同时携带PNPLA3 rs738409与TM6SF2 rs58542926可解释该人群中肝细胞癌归因风险的一半。
  • 作者认为基因分型将有助于对酒精性肝硬化患者进行更精确的肝细胞癌风险分层,基因型指导的筛查算法可优化患者管理。

研究设计与样本

  • 研究对751例酒精性肝硬化合并肝细胞癌病例与1165例酒精性肝硬化无肝细胞癌对照进行PNPLA3、TM6SF2和MBOAT7风险变异基因分型。
  • 采用多因素logistic回归分析基因变异与肝细胞癌发生风险的关联,校正性别、年龄、体重指数和2型糖尿病。

主要发现

  • 采用加性模型并校正性别、年龄、体重指数和2型糖尿病后,肝细胞癌发生与PNPLA3 rs738409独立相关(ORadjusted 1.84,95%CI 1.55-2.18,p=1.85×10-12)。
  • 肝细胞癌发生与TM6SF2 rs58542926独立相关(ORadjusted 1.66,95%CI 1.30-2.13,p=5.13×10-05)。
  • MBOAT7 rs641738携带与肝细胞癌风险的关联不显著(ORadjusted 1.04,95%CI 0.88-1.24,p=0.61)。
  • 人群归因分数PNPLA3 rs738409为43.5%,TM6SF2 rs58542926为11.5%,两者同时携带合计为49.9%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Variants in patatin-like phospholipase domain-containing 3 (PNPLA3; rs738409), transmembrane 6 superfamily member 2 (TM6SF2; rs58542926), and membrane bound O-acyltransferase domain containing 7 (MBOAT7; rs641738) are risk factors for the development of alcohol-related cirrhosis. Within this population, PNPLA3 rs738409 is also an established risk factor for the development of hepatocellular carcinoma (HCC). The aim of this study was to explore possible risk associations of TM6SF2 rs58542926 and MBOAT7 rs641738 with HCC. METHODS: Risk variants in PNPLA3, TM6SF2, and MBOAT7 were genotyped in 751 cases with alcohol-related cirrhosis and HCC and in 1165 controls with alcohol-related cirrhosis without HCC. Association with the risk of developing HCC was analyzed using multivariate logistic regression. RESULTS: The development of HCC was independently associated with PNPLA3 rs738409 (ORadjusted 1.84 [95% CI 1.55-2.18], p = 1.85 × 10-12) and TM6SF2 rs58542926 (ORadjusted 1.66 [1.30-2.13], p = 5.13 × 10-05), using an additive model, and controlling the sex, age, body mass index, and type 2 diabetes mellitus; the risk associated with carriage of MBOAT7 rs641738 (ORadjusted 1.04 [0.88-1.24], p = 0.61) was not significant. The population-attributable fractions were 43.5% for PNPLA3 rs738409, 11.5% for TM6SF2 rs58542926, and 49.9% for the carriage of both the variants combined. CONCLUSIONS: Carriage of TM6SF2 rs58542926 is an additional risk factor for the development of HCC in people with alcohol-related cirrhosis. Carriage of both PNPLA3 rs738409 and TM6SF2 rs58542926 accounts for half of the attributable risk for HCC in this population. Genotyping will allow for more precise HCC risk-stratification of patients with alcohol-related cirrhosis, and genotype-guided screening algorithms would optimize patient care.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Stickel F, Buch S, Nischalke HD, et al. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Am J Gastroenterol. 2018. PMID: 29535416. doi:10.1038/s41395-018-0041-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。